Fractional Laser Resurfacing: What Your Skin Does Each Week
Sudha Mishra | Updated:
Fractional Laser Resurfacing: What Your Skin Does Each Week
Image credit : AI
Recovery after fractional laser resurfacing requires careful aftercare. This image evokes a sense of gentle healing.
Fractional laser resurfacing leaves thousands of microscopic wounds in the skin, on purpose. What happens in the days and weeks after is a precise biological sequence, not a mystery. Understanding that sequence tells you what is normal, what is not, and why rushing the process costs you the result you paid for.
Highlights
- Fractional laser resurfacing employs a grid of tiny, concentrated light beams to create microthermal zones in the skin, promoting faster healing by leaving surrounding tissue intact.
- During the first week post-treatment, the skin experiences redness, swelling, and peeling, with a critical importance on maintaining moisture and avoiding any picking to reduce the risk of scarring.
- Ablative fractional resurfacing is not suitable for everyone; contraindications include active acne, a history of keloid or hypertrophic scarring, and recent use of oral isotretinoin, requiring careful consideration before treatment.
Fractional laser resurfacing works by firing a grid of tiny, concentrated light beams into the skin. Each beam creates a column of controlled thermal injury, called a microthermal zone, while leaving the surrounding tissue intact. That intact tissue is the key: it provides a reservoir of healthy cells that drives repair far faster than if the entire surface were treated at once. The depth of those columns, and how densely they are packed, determines both the result and the recovery. Ablative fractional lasers such as CO2 and erbium remove tissue; non-ablative fractional lasers heat it without breaking the surface. Ablative devices produce more significant changes and longer downtime. This piece covers the ablative track, because that is where the week-by-week timeline is most clinically meaningful.
Immediately after the session, the treated skin looks red, swollen, and feels hot, similar to a moderate sunburn, but more uniform. By the next morning, swelling typically peaks, particularly around the eyes if the face was fully treated. The skin surface begins to weep a clear or slightly yellowish fluid: this is serous exudate, not infection. It is part of the inflammatory phase of wound healing, in which the body rushes blood flow and immune cells to the area. Keeping the skin moist with a plain, fragrance-free ointment during this phase is not optional comfort care. A moist wound environment allows keratinocytes, the cells that rebuild the outer skin layer, to migrate across the microthermal zones roughly twice as fast as they do on a dry surface. Washing the face gently two to three times a day and reapplying ointment immediately after is the standard protocol most practitioners recommend. Anything that disrupts this moisture barrier, alcohol-based products, actives, physical scrubbing, slows re-epithelialisation and increases the risk of post-inflammatory pigmentation, which is a particular concern for medium and deeper skin tones.
The exudate dries and the skin takes on a dark, bronzed, or grid-like texture. This is the treated tissue reaching the surface as the new epidermis pushes up from beneath. It looks alarming; it is progress. The skin will begin to peel, sometimes in large sheets, sometimes in fine flakes depending on treatment depth and individual skin behaviour. The rule here is absolute: do not pull, peel, or pick. Premature removal of this tissue before the underlying epidermis has fully closed exposes raw skin, increases the risk of scarring, and can introduce bacteria. The itch is real and is driven by histamine release during healing. A cool compress provides more relief than any topical antihistamine and carries no risk of product interaction at a vulnerable stage. By day 7, most of the surface peeling is complete in lighter skin tones; in darker skin tones, the process may extend a few days further. Sun exposure during this window is not a matter of preference, UV hitting actively healing skin is a direct cause of post-inflammatory hyperpigmentation.
By the start of the second week, the skin looks presentable. Redness has faded to pink, the surface feels smooth, and many people return to work and light social activity. What is not visible is that the dermis, the deeper structural layer, is in the middle of its remodelling phase. Fibroblasts are synthesising new collagen and elastin in the treated columns. This process has barely begun. The skin at this stage is also more fragile than it looks: the new epidermis is thinner than fully mature skin, and the acid mantle, the skin's pH-protective barrier, has not fully re-established. This is the week when people are most likely to reintroduce retinoids, vitamin C serums, or exfoliating acids too early, and then wonder why they experience stinging, redness, or a flare of pigmentation. Most practitioners advise waiting until at least week four before reintroducing any active ingredient, and until week six or beyond for prescription-strength retinoids.
Collagen remodelling is slow. The fibroblast activity that began in week one continues for months, but weeks three through six are when the structural changes start to become clinically visible, pore size, skin texture, and the depth of superficial lines begin to shift. Redness that persists beyond week three is common, particularly in fair skin, and does not indicate a complication. It reflects ongoing vascular activity in the healing dermis. Camouflage makeup with mineral-based formulas is generally tolerated by week three, but patch-testing on a small area first is sensible. SPF is non-negotiable throughout this window and for at least three months post-treatment, not because the skin is raw, but because newly remodelled tissue is more susceptible to UV-induced pigment changes than mature skin. People with a history of melasma, or those with Fitzpatrick skin types IV through VI, carry a higher risk of post-inflammatory hyperpigmentation and should discuss pre-treatment and post-treatment pigment management with their practitioner before booking.
Ablative fractional resurfacing is not appropriate for everyone. Active acne is a contraindication: treating inflamed skin risks spreading bacteria and worsening scarring. A history of keloid or hypertrophic scarring warrants a detailed conversation with a dermatologist before proceeding. People who have taken oral isotretinoin within the past twelve months are generally advised to wait, because the drug alters sebaceous gland function and may impair normal wound healing, though the exact waiting period varies and is a decision for the treating clinician. Darker skin tones are not excluded, but the parameters must be adjusted, lower energy densities, longer intervals between sessions, and the practitioner's experience with those skin tones matters as much as the device itself. The honest version of this treatment is that it works, recovery is real, and the result builds over months rather than weeks. Anyone who tells you otherwise is selling the session, not the outcome.
Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!
Days 1 to 3: The Wound Response
Days 4 to 7: Bronzing, Peeling, and the Urge to Pick
Week 2: The Deceptive Plateau
Weeks 3 to 6: Collagen Synthesis and Continued Sensitivity
Who Should Think Carefully Before Booking
Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!